Bruce & Co., Inc.: Q2 2026 Portfolio Changes Detailed
This analysis details the significant stock purchases and sales by Bruce & Co., Inc. during the second quarter of 2026, based on available filing data.
As part of its regular portfolio adjustments, Bruce & Co., Inc. made several notable changes during the second quarter ending June 30, 2026. The firm managed a total portfolio value of approximately $306 million at that date, with holdings spread across various sectors and stocks as disclosed in regulatory filings.
Prominent Purchases This Quarter
Several companies saw significant increases in their shareholdings during Q2 2026:
- Supernus Pharmaceuticals (SUPN), operating within the Healthcare sector, experienced a substantial increase of 500,000 shares. This represents a significant addition to their portfolio allocation.
- AerCap Holdings (AER), involved in the sector categorized as 'Unknown' for this data, saw an increase of just over 1,500 shares. This modest addition suggests a targeted approach to specific opportunities.
Furthermore, Fate Therapeutics (FATE), another Healthcare stock, was noted as a new position acquired by Bruce & Co., Inc. during this period.
Notable Sales and Decreases
The firm also reduced its positions in several key holdings:
- Abbvie (ABBV), a major player in the Healthcare sector, saw a decrease of just over 1,000 shares. This minor reduction might indicate ongoing monitoring or rebalancing efforts.
- Allstate (ALL), in the Financial Services sector, experienced a decrease of over 3,000 shares. This suggests a strategic reduction in exposure to this insurer.
- Uhaul B (UHAL-B), part of the Industrials sector, saw one of the largest reductions with a decrease of over 35,000 shares. This significant sell-off could signal a shift in investment focus.
- Vicor (VICR), from the Technology sector, was sold off significantly with over 17,000 shares reduced. This indicates a major divestment activity.
Several other holdings also decreased during Q2:
- Uhaul (UHAL): Decreased by over 1,300 shares
- AT & T (T), in the Communication Services sector: Decreased by 5,000 shares
- Pfizer (PFE), a Healthcare stock: Decreased by over 3,700 shares
- Apple (AAPL), from the Technology sector: Decreased by 2,000 shares
- XCEL Energy (XEL), a Utilities stock: Decreased by 2,000 shares
- CMS Energy (CMS), another Utilities stock: Decreased by 3,000 shares
- Avista (AVA), a Utilities stock: Decreased by 1,500 shares
These changes reflect the firm's dynamic investment strategy. The data shows that Bruce & Co., Inc. holds 35 stocks in its portfolio and has maintained an allocation where the top five holdings account for approximately 34.9% of the total value, indicating a concentrated approach to diversification.
Sector Allocation Insights
Bruce & Co.'s portfolio remains diversified across eight sectors:
- Healthcare: Comprising about 23.85% of the total value, this sector is heavily weighted with significant holdings like AbbVie and several smaller buys.
- Utilities: Holding roughly 17.43% in stocks such as Duke Energy, CMS Energy, XCEL Energy, and Avista.
- Industrials: Representing approximately 13.55% of the portfolio value.
- Unknown Sector: Accounting for about 12.29% of the total holdings.
The remaining allocations are distributed among Financial Services (around 10.3%), Technology (about 9.45%), Communication Services (~4.04%), Consumer Defensive (~4.37%), and Basic Materials (~4.73%). The disclosed data indicates that the firm has a history of making substantial purchases but no large sales during this reporting period.